Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Bago JR"'
Autor:
Celichowski P; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Turi M; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Faculty of Science, University of Ostrava, Ostrava, Czech Republic., Charvátová S; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Faculty of Science, University of Ostrava, Ostrava, Czech Republic., Radhakrishnan D; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Faculty of Science, University of Ostrava, Ostrava, Czech Republic., Feizi N; Department of Internal Clinical Sciences, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy., Chyra Z; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Šimíček M; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Jelínek T; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Bago JR; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Hájek R; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Hrdinka M; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. matous.hrdinka@fno.cz.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. matous.hrdinka@fno.cz.
Publikováno v:
Journal of translational medicine [J Transl Med] 2023 Mar 15; Vol. 21 (1), pp. 197. Date of Electronic Publication: 2023 Mar 15.
Autor:
Zátopková M; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic., Ševčíková T; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic., Fanfani V; Institute of Quantitative Biology, Biochemistry and Biotechnology, University of Edinburgh, Edinburgh, United Kingdom., Chyra Z; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Říhová L; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic., Bezděková R; Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic., Žihala D; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic., Growková K; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic., Filipová J; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Černá L; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Broskevičova L; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Kryukov F; Clinical Development Department, Joint-stock Company BIOCAD, Saint Petersburg, Russia., Minařík J; Department of Hematooncology, University Hospital and Palacky University Olomouc, Olomouc, Czech Republic., Smejkalová J; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Maisnar V; 4th Department of Medicine-Haematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic., Harvanová Ĺ; Department of Hematology and Transfusiology, University Hospital Bratislava, Bratislava, Slovakia., Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic; and., Jungova A; Department of Hemato-Oncology, Charles University Hospital Pilsen, Pilsen, Czech Republic., Popková T; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Bago JR; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Anilkumar Sithara A; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Hrdinka M; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic., Jelínek T; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic., Šimíček M; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.; Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic., Stracquadanio G; Institute of Quantitative Biology, Biochemistry and Biotechnology, University of Edinburgh, Edinburgh, United Kingdom., Hájek R; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
Publikováno v:
Blood advances [Blood Adv] 2022 Jan 25; Vol. 6 (2), pp. 368-372.
Autor:
Venglar O; Faculty of Science, University of Ostrava, Ostrava, Czechia.; Faculty of Medicine, University of Ostrava, Ostrava, Czechia.; Hematooncology Clinic, University Hospital Ostrava, Ostrava, Czechia., Bago JR; Faculty of Medicine, University of Ostrava, Ostrava, Czechia.; Hematooncology Clinic, University Hospital Ostrava, Ostrava, Czechia., Motais B; Faculty of Science, University of Ostrava, Ostrava, Czechia.; Faculty of Medicine, University of Ostrava, Ostrava, Czechia., Hajek R; Faculty of Medicine, University of Ostrava, Ostrava, Czechia.; Hematooncology Clinic, University Hospital Ostrava, Ostrava, Czechia., Jelinek T; Faculty of Medicine, University of Ostrava, Ostrava, Czechia.; Hematooncology Clinic, University Hospital Ostrava, Ostrava, Czechia.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Jan 11; Vol. 12, pp. 816499. Date of Electronic Publication: 2022 Jan 11 (Print Publication: 2021).
Autor:
Mercer-Smith AR; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Jiang W; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Bago JR; Department of Hemato-Oncology, University of Ostrava, Ostrava, Czech Republic., Valdivia A; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Thang M; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Woodell AS; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Montgomery SA; Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Sheets KT; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Anders CK; Department of Medicine, Duke University, Durham, North Carolina., Hingtgen SD; Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. hingtgen@email.unc.edu.; Department of Neurosurgery, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Nov; Vol. 20 (11), pp. 2291-2301. Date of Electronic Publication: 2021 Aug 25.
Autor:
Carey-Ewend AG; Department of Pharmaceutical Sciences, Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Hagler SB; Department of Pharmaceutical Sciences, Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Bomba HN; Department of Pharmaceutical Sciences, Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Goetz MJ; Department of Pharmaceutical Sciences, Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Bago JR; Department of Hemato-Oncology, University Hospital of Ostrava, Ostrava, Czech Republic., Hingtgen SD; Department of Pharmaceutical Sciences, Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
Tissue engineering. Part A [Tissue Eng Part A] 2021 Jul; Vol. 27 (13-14), pp. 857-866. Date of Electronic Publication: 2020 Oct 20.
Autor:
Jiang W; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27588, USA., Yang Y; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27588, USA.; McAllister Heart Institute, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27588, USA., Mercer-Smith AR; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27588, USA., Valdivia A; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27588, USA., Bago JR; Department of Hemato-Oncology, University Hospital of Ostrava, 708 52 Ostrava, Czech Republic.; Faculty of Medicine, University of Ostrava, 703 00 Ostrava, Czech Republic., Woodell AS; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27588, USA., Buckley AA; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27588, USA., Marand MH; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27588, USA., Qian L; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27588, USA.; McAllister Heart Institute, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27588, USA., Anders CK; Department of Medicine, Duke University, North Carolina, 27710, USA., Hingtgen SD; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27588, USA. hingtgen@email.unc.edu.; Department of Neurosurgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27588, USA.
Publikováno v:
Science advances [Sci Adv] 2021 Jun 09; Vol. 7 (24). Date of Electronic Publication: 2021 Jun 09 (Print Publication: 2021).
Autor:
Demel I; Department of Haemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic., Bago JR; Department of Haemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic.; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Hajek R; Department of Haemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic.; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Jelinek T; Department of Haemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic.; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Publikováno v:
British journal of haematology [Br J Haematol] 2021 May; Vol. 193 (4), pp. 705-722. Date of Electronic Publication: 2020 Nov 20.
Autor:
Carey-Ewend AG; Department of Pharmaceutical Sciences, Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Hagler SB; Department of Pharmaceutical Sciences, Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Bomba HN; Department of Pharmaceutical Sciences, Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Goetz MJ; Department of Pharmaceutical Sciences, Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Bago JR; Department of Hemato-Oncology, University Hospital of Ostrava, Ostrava, Czech Republic., Hingtgen SD; Department of Pharmaceutical Sciences, Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
Tissue engineering. Part A [Tissue Eng Part A] 2020 Oct 20. Date of Electronic Publication: 2020 Oct 20.
Autor:
Haney MJ; Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7362, USA., Zhao Y; Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7362, USA., Jin YS; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7362, USA., Li SM; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7362, USA., Bago JR; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7362, USA., Klyachko NL; Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7362, USA.; Deparment of Chemical Enzymology, Faculty of Chemistry, M.V. Lomonosov Moscow State University, Moscow, Russia., Kabanov AV; Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7362, USA.; Deparment of Chemical Enzymology, Faculty of Chemistry, M.V. Lomonosov Moscow State University, Moscow, Russia., Batrakova EV; Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. batrakov@ad.unc.edu.; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7362, USA. batrakov@ad.unc.edu.
Publikováno v:
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology [J Neuroimmune Pharmacol] 2020 Sep; Vol. 15 (3), pp. 487-500. Date of Electronic Publication: 2019 Nov 13.
Autor:
Sahinbegovic H; Department of Clinical Studies, Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 70200 Ostrava, Czech Republic.; Faculty of Science, University of Ostrava, 70800 Ostrava, Czech Republic.; Faculty of Genetics and Bioengineering, International Burch University, 71210 Sarajevo, Bosnia and Herzegovina., Jelinek T; Department of Clinical Studies, Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 70200 Ostrava, Czech Republic., Hrdinka M; Department of Clinical Studies, Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 70200 Ostrava, Czech Republic., Bago JR; Department of Clinical Studies, Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 70200 Ostrava, Czech Republic., Turi M; Department of Clinical Studies, Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic.; Faculty of Science, University of Ostrava, 70800 Ostrava, Czech Republic., Sevcikova T; Department of Clinical Studies, Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 70200 Ostrava, Czech Republic.; Faculty of Science, University of Ostrava, 70800 Ostrava, Czech Republic., Kurtovic-Kozaric A; Faculty of Genetics and Bioengineering, International Burch University, 71210 Sarajevo, Bosnia and Herzegovina., Hajek R; Department of Clinical Studies, Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 70200 Ostrava, Czech Republic., Simicek M; Department of Clinical Studies, Faculty of Medicine, University of Ostrava, 70300 Ostrava, Czech Republic.; Department of Hematooncology, University Hospital Ostrava, 70200 Ostrava, Czech Republic.; Faculty of Science, University of Ostrava, 70800 Ostrava, Czech Republic.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Jul 04; Vol. 12 (7). Date of Electronic Publication: 2020 Jul 04.